Skip to main content
. 2020 Oct 18;11(24):7137–7145. doi: 10.7150/jca.49213

Figure 3.

Figure 3

Clinicopathological and treatment characteristics were associated with OS of NSCLC patients with ICIs treatment. A. Age correlated with the OS for ICIs treatment (P < 0.001). B. Number of metastatic organ affected the OS of ICIs treatment (P = 0.03). C. Treatment response to ICIs affected OS of NSCLC patients (P < 0.001). D. Response to ICIs affected the OS of ICIs treatment (P = 0.03). E. irAE (< G2 / ≥ G2) affected the OS of ICIs treatment (P = 0.01).